Does IOBENGUANE I-131 Cause Disease progression? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Disease progression have been filed in association with IOBENGUANE I-131. This represents 13.0% of all adverse event reports for IOBENGUANE I-131.
16
Reports of Disease progression with IOBENGUANE I-131
13.0%
of all IOBENGUANE I-131 reports
3
Deaths
3
Hospitalizations
How Dangerous Is Disease progression From IOBENGUANE I-131?
Of the 16 reports, 3 (18.8%) resulted in death, 3 (18.8%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IOBENGUANE I-131. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does IOBENGUANE I-131 Cause?
Neutropenia (25)
Mucosal inflammation (15)
Thrombocytopenia (13)
Anaemia (12)
Product use in unapproved indication (11)
Platelet count decreased (8)
Febrile neutropenia (7)
Nausea (7)
Pyrexia (7)
Vomiting (7)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which IOBENGUANE I-131 Alternatives Have Lower Disease progression Risk?
IOBENGUANE I-131 vs IOBITRIDOL
IOBENGUANE I-131 vs IODINE
IOBENGUANE I-131 vs IODINE\IOFLUPANE I-123
IOBENGUANE I-131 vs IODIXANOL
IOBENGUANE I-131 vs IOHEXOL